Compositions comprising immunostimulatory oligonucleotides (CpG ODN) and FcR-directed immunotherapeutics are disclosed. Also disclosed are methods of using the compositions to enhance FcR-mediated antigen presentation, ADCC, and other FcR-mediated immune responses. ...http://www.google.fr/patents/US20030072762?utm_source=gb-gplus-shareBrevet US20030072762 - Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance Fc receptor-mediated immunotherapies
Compositions comprising immunostimulatory oligonucleotides and uses thereof ...
